News & Events

Collaborating for Cures Leveraging Global Public-Private Partnerships to Accelerate Biopharmaceuticals Development

Event Date: 03/07/2013 The Innovative Medicines Initiative (IMI) and Critical Path Institute (C-Path) held a joint event in Brussels, Belgium on the challenges and opportunities of public-private partnerships (PPPs). More than 120 participants attended the conference and many more followed the live webcast. This first ever public conference co-sponsored by IMI and C-Path featured cross-sector […]

Critical Path for Parkinson’s: The Journey Begins!

Diane Stephenson, Executive Director CPP, visited Parkinson’s UK for the first time in London on June 3, 2013 to start the wheels in motion for laying the groundwork for CPP.

Leading US and European Medical Public-Private Partnerships Announce Agreement

The Predictive Safety Testing Consortium (PSTC) led by the Critical Path Institute (C-Path) and the Safer and Faster Evidence-based Translation (SAFE-T) consortium sponsored by the Innovative Medicines Initiative (IMI), announced today the signature of an agreement to work together in their efforts to improve drug safety.

Advancing Adoption of Novel Safety Biomarkers into Drug Development through Voluntary Submission of Data at US FDA, EMA, and PMDA

Presenter – E Gribble Walker, M Brumfield, E H Dennis Conference – Society of Toxicologists 2013 Annual Meeting